Effect of adenotonsillar hypertrophy on right ventricle function in children

Jin Hwan Lee1, Jung Min Yoon1, Jae Woo Lim1

  • 1Department of Pediatrics, Konyang University College of Medicine, Daejeon, Korea.

Insights

Children with adenotonsillar hypertrophy (ATH) show elevated N-terminal of probrain natriuretic peptide (NT-proBNP) levels, indicating potential cardiac dysfunction. Echocardiography did not reveal significant right ventricle (RV) dysfunction, but NT-proBNP suggests underlying risks.

Area of Science:

  • Pediatric Cardiology
  • Pulmonology
  • Biomarkers

Background:

  • Chronic upper airway obstruction, common in children with adenotonsillar hypertrophy (ATH), can lead to hypoxemic pulmonary vasoconstriction and right ventricle (RV) dysfunction.
  • ATH is a prevalent cause of upper airway obstruction in pediatric populations.

Purpose of the Study:

  • To evaluate right ventricle (RV) function in children diagnosed with adenotonsillar hypertrophy (ATH).
  • To investigate the correlation between ATH and potential cardiac dysfunction markers.

Main Methods:

  • Inclusion of 21 children with ATH and 21 age- and gender-matched healthy controls.
  • Assessment of RV function using tricuspid annular plane systolic excursion and RV myocardial performance index via transthoracic echocardiography.
  • Measurement of plasma N-terminal of probrain natriuretic peptide (NT-proBNP) levels as an indicator of RV function.

Main Results:

  • Loud snoring was a common symptom reported in the ATH group via the STOP questionnaire.
  • Plasma NT-proBNP levels were significantly higher in children with ATH compared to controls (66.44±37.63 pg/mL vs. 27.85±8.89 pg/mL, P=0.001).
  • No significant differences in echocardiographic parameters for RV function were observed between the groups.

Conclusions:

  • While echocardiographic evidence of RV dysfunction was not confirmed, elevated NT-proBNP suggests a potential risk for cardiac dysfunction in children with chronic airway obstruction due to ATH.
  • Further research with larger patient cohorts and transthoracic echocardiography is warranted.
  • Pediatricians and otolaryngologists should consider cardiac implications in the management of children with severe ATH.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.0K
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
5